NCT00646776View on ClinicalTrials.gov

Drug Interaction Study

PHASE1CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Antivirals/HIV
Interventions
DRUG

Rifabutin

Capsule, Oral, 150 mg, once daily, 11 Days

DRUG

Rifabutin + Atazanavir + Ritonavir

"Capsules, Oral, 18 Days~Rifabutin (150 mg, 2x/wk)~Atazanavir (300 mg, once daily)~Ritonavir (100 mg, once daily)"

Trial Locations (1)

08690

Bristol-Myers Squibb Clinical Pharmacology Unit, Hamilton

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00646776 - Drug Interaction Study | Biotech Hunter | Biotech Hunter